Get Getting Benefits Under Social Security With HCV ( Hepatitis C)

Hepatitis C is a virus that can infect the liver. If left untreated, it can sometimes cause serious and potentially life-threatening damage to the liver over many years. However, with modern treatments it's easily possible to cure the infection and most people with it will have a normal life expectancy.

► A reactive or positive antibody test means you have been infected with the hepatitis C virus at some point in time. ► Once people have been infected, they will always have antibodies in their blood. This is true if they have cleared the virus, have been cured, or still have the virus in their blood.

Here's an amazing fact: Once you're cured of Hepatitis C, liver damage stops. And over time (different for everyone, but possibly five years or more), your liver can heal itself through regeneration. That's right, the thing grows back!

Generally, you don't have to tell anybody that you have hepatitis, but there are four exceptions: Healthcare workers engaging in 'invasive or exposure prone procedures'. This means surgery or other procedures that may require a nurse, surgeon or other healthcare provider to work inside the body of another person.

Getting VA disability benefits for hepatitis C is not impossible, but it can be difficult. It is common for the virus to lie dormant in the body for decades before causing symptoms, which makes it difficult to establish a service connection.

Yes. Prior infection with HCV does not protect against later infection with the same or different genotypes of the virus. This is because people infected with HCV typically have an ineffective immune response due to changes in the virus during infection.

An individual may qualify for SSDI and/or SSI for any number of conditions, including chronic liver disease or cirrhosis. If your liver disease has progressed to the point where you can no longer work, then your application for disability benefits may be approved.

With proper treatment, many people can be cured from hepatitis C infection and live healthy lives. WHO recommends therapy with pan-genotypic direct-acting antivirals (DAAs) for all adults, adolescents and children down to 3 years of age with chronic hepatitis C infection.